About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
Prof. Yair Reisner is expert at tricking the immune system into accepting trans¬plants it would normally reject. He made a lifesaving breakthrough that lets immunocompromised patients receive bone marrow from a mismatched donor, then expanded the method to leukemia patients – and as if that's not enough, he's now applying it to organ transplants.
Lung cancer, the world's deadliest cancer, can be apparently successfully treated, only to return. And when it does so, it's often resistant to the drugs that worked the first time. Fortunately, Prof. Yosef Yarden has devised a novel three-pronged strategy that, in mice, kept lung cancer cells from developing resistance in the first place.
June 03, 2015
Prostate cancer is the second leading cause of cancer-related deaths among American men. That's why Prof. Avigdor Scherz, collaborating with other leading cancer researchers, is developing a promising new treatment: vascular-targeted photodynamic therapy, or VTP. Now in clinical trials, VTP uses light and a unique drug to destroy prostate tumors.
May is Melanoma/Skin Cancer Detection and Prevention Month: the perfect opportunity to learn more about the disease – and what the Weizmann Institute of Science is doing to help.
Cells send a constant stream of messages to their nuclei for making day-to-day decisions. But this rapid, long-distance communication system is vulnerable to mutations that can lead to unstopped, repeated messages – a “spam attack” – that promotes cancer. Now, Prof. Rony Seger and his team have identified a molecule that stops cancer cells from getting their “mail.""
March 30, 2015
Seeing a clear need for a fresh approach to cancer research, the Weizmann Institute established the Moross Integrated Cancer Center (MICC). By collaborating with researchers and physicians; focusing on prevention, diagnosis, and treatment; and working to move therapies from the lab to the clinic, the MICC is a powerful new weapon in the war on cancer.
January 28, 2015
Prof. Michal Neeman spoke at the 2014 Global Gathering session, Partners in Scientific Advancement, about why it's so important for us to get high-resolution images of cancer. Today's instrumentation allows scientists to actually observe cancer in the body, providing invaluable new data. Of course, staying on top of the technology, much less knowing how to maximize its use, is also a challenge.
October 29, 2014
Dr. Siddhartha Mukherjee, one of today's most engaging science communicators and author of the Pulitzer Prize-winning ""The Emperor of All Maladies: A Biography of Cancer,"" managed to compress the whole history of cancer studies, from primitive to sophisticated, as well a look to the future, into a few comprehensible, enjoyable minutes.
Time reports on the recent finding by Weizmann scientists that our bodies fight cancer better during the day, meaning that nighttime might be much better for administering cancer drugs. This “happy accident” is an example of how basic research can shed light on important issues.
October 09, 2014
©2020 American Committee for the Weizmann Institute of Science